Advertisement

Index by author

September 01, 2002; Volume 30,Issue 9

A

  1. Anakk, Sayeepriyadarshini

    1. Sexual Dimorphism and Tissue Specificity in the Expression of CYP4F Forms in Sprague Dawley Rats
      Auinash Kalsotra, Sayeepriyadarshini Anakk, Christopher L. Boehme and Henry W. Strobel
      Drug Metabolism and Disposition September 2002, 30 (9) 1022-1028; DOI: https://doi.org/10.1124/dmd.30.9.1022

B

  1. Batty, Kevin T.

    1. Glucuronidation of Dihydroartemisinin in Vivo and by Human Liver Microsomes and Expressed UDP-Glucuronosyltransferases
      Kenneth F. Ilett, Brian T. Ethell, James L. Maggs, Timothy M. E. Davis, Kevin T. Batty, Brian Burchell, Tran Quang Binh, Le Thi Anh Thu, Nguyen Canh Hung, Munir Pirmohamed, B. Kevin Park and Geoffrey Edwards
      Drug Metabolism and Disposition September 2002, 30 (9) 1005-1012; DOI: https://doi.org/10.1124/dmd.30.9.1005

  2. Bible, Roy

    1. Disposition of a Specific Cyclooxygenase-2 Inhibitor, Valdecoxib, in Human
      Josh J. Yuan, Dai-chang Yang, Ji Y. Zhang, Roy Bible, Aziz Karim and John W. A. Findlay
      Drug Metabolism and Disposition September 2002, 30 (9) 1013-1021; DOI: https://doi.org/10.1124/dmd.30.9.1013

  3. Binh, Tran Quang

    1. Glucuronidation of Dihydroartemisinin in Vivo and by Human Liver Microsomes and Expressed UDP-Glucuronosyltransferases
      Kenneth F. Ilett, Brian T. Ethell, James L. Maggs, Timothy M. E. Davis, Kevin T. Batty, Brian Burchell, Tran Quang Binh, Le Thi Anh Thu, Nguyen Canh Hung, Munir Pirmohamed, B. Kevin Park and Geoffrey Edwards
      Drug Metabolism and Disposition September 2002, 30 (9) 1005-1012; DOI: https://doi.org/10.1124/dmd.30.9.1005

  4. Binkley, Shelly N.

    1. The Interactions of a Selective Protein Kinase C Beta Inhibitor with the Human Cytochromes P450
      Barbara J. Ring, Jennifer S. Gillespie, Shelly N. Binkley, Kristina M. Campanale and Steven A. Wrighton
      Drug Metabolism and Disposition September 2002, 30 (9) 957-961; DOI: https://doi.org/10.1124/dmd.30.9.957

  5. Boehme, Christopher L.

    1. Sexual Dimorphism and Tissue Specificity in the Expression of CYP4F Forms in Sprague Dawley Rats
      Auinash Kalsotra, Sayeepriyadarshini Anakk, Christopher L. Boehme and Henry W. Strobel
      Drug Metabolism and Disposition September 2002, 30 (9) 1022-1028; DOI: https://doi.org/10.1124/dmd.30.9.1022

  6. Bombail, Vincent

    1. Glucocorticoid-Mediated Induction of CYP3A4 is Decreased by Disruption of a Protein: DNA Interaction Distinct from the Pregnane X Receptor Response Element
      Wafaa El-Sankary, Vincent Bombail, G. Gordon Gibson and Nick Plant
      Drug Metabolism and Disposition September 2002, 30 (9) 1029-1034; DOI: https://doi.org/10.1124/dmd.30.9.1029

  7. Brouwer, Kim L. R.

    1. Mechanisms of Impaired Biliary Excretion of Acetaminophen Glucuronide after Acute Phenobarbital Treatment or Phenobarbital Pretreatment
      Hao Xiong, Hiroshi Suzuki, Yuichi Sugiyama, Peter J. Meier, Gary M. Pollack and Kim L. R. Brouwer
      Drug Metabolism and Disposition September 2002, 30 (9) 962-969; DOI: https://doi.org/10.1124/dmd.30.9.962

  8. Burchell, Brian

    1. Glucuronidation of Dihydroartemisinin in Vivo and by Human Liver Microsomes and Expressed UDP-Glucuronosyltransferases
      Kenneth F. Ilett, Brian T. Ethell, James L. Maggs, Timothy M. E. Davis, Kevin T. Batty, Brian Burchell, Tran Quang Binh, Le Thi Anh Thu, Nguyen Canh Hung, Munir Pirmohamed, B. Kevin Park and Geoffrey Edwards
      Drug Metabolism and Disposition September 2002, 30 (9) 1005-1012; DOI: https://doi.org/10.1124/dmd.30.9.1005

C

  1. Cai, Hongbo

    1. Effects of Bergamottin on Human and Monkey Drug-Metabolizing Enzymes in Primary Cultured Hepatocytes
      Yuan Hua Wen, Jasminder Sahi, Ellen Urda, Shaila Kulkarni, Kelly Rose, Xianxian Zheng, Jacqueline F. Sinclair, Hongbo Cai, Stephen C. Strom and Vsevolod E. Kostrubsky
      Drug Metabolism and Disposition September 2002, 30 (9) 977-984; DOI: https://doi.org/10.1124/dmd.30.9.977

  2. Campanale, Kristina M.

    1. The Interactions of a Selective Protein Kinase C Beta Inhibitor with the Human Cytochromes P450
      Barbara J. Ring, Jennifer S. Gillespie, Shelly N. Binkley, Kristina M. Campanale and Steven A. Wrighton
      Drug Metabolism and Disposition September 2002, 30 (9) 957-961; DOI: https://doi.org/10.1124/dmd.30.9.957

  3. Cheng, K.-C.

    1. Insights from a Three-Dimensional Model into Ligand Binding to Constitutive Active Receptor
      Li Xiao, Xiaoming Cui, Vincent Madison, Ronald E. White and K.-C. Cheng
      Drug Metabolism and Disposition September 2002, 30 (9) 951-956; DOI: https://doi.org/10.1124/dmd.30.9.951

  4. Chow, Toshio

    1. Catalytic Specificity of CYP2D Isoforms in Rat and Human
      Toyoko Hiroi, Toshio Chow, Susumu Imaoka and Yoshihiko Funae
      Drug Metabolism and Disposition September 2002, 30 (9) 970-976; DOI: https://doi.org/10.1124/dmd.30.9.970

  5. Correia, Maria Almira

    1. Differential Oxidation of Mifepristone by Cytochromes P450 3A4 and 3A5: Selective Inactivation of P450 3A4
      Kishore K. Khan, You Qun He, Maria Almira Correia and James R. Halpert
      Drug Metabolism and Disposition September 2002, 30 (9) 985-990; DOI: https://doi.org/10.1124/dmd.30.9.985

  6. Cui, Xiaoming

    1. Insights from a Three-Dimensional Model into Ligand Binding to Constitutive Active Receptor
      Li Xiao, Xiaoming Cui, Vincent Madison, Ronald E. White and K.-C. Cheng
      Drug Metabolism and Disposition September 2002, 30 (9) 951-956; DOI: https://doi.org/10.1124/dmd.30.9.951

D

  1. Dahn, Michael S.

    1. Effects of Dexamethasone on Aryl (SULT1A1)- and Hydroxysteroid (SULT2A1)-Sulfotransferase Gene Expression in Primary Cultured Human Hepatocytes
      Zhengbo Duanmu, Deborah Locke, Jeffrey Smigelski, Wei Wu, Michael S. Dahn, Charles N. Falany, Thomas A. Kocarek and Melissa Runge-Morris
      Drug Metabolism and Disposition September 2002, 30 (9) 997-1004; DOI: https://doi.org/10.1124/dmd.30.9.997

  2. Davis, Timothy M. E.

    1. Glucuronidation of Dihydroartemisinin in Vivo and by Human Liver Microsomes and Expressed UDP-Glucuronosyltransferases
      Kenneth F. Ilett, Brian T. Ethell, James L. Maggs, Timothy M. E. Davis, Kevin T. Batty, Brian Burchell, Tran Quang Binh, Le Thi Anh Thu, Nguyen Canh Hung, Munir Pirmohamed, B. Kevin Park and Geoffrey Edwards
      Drug Metabolism and Disposition September 2002, 30 (9) 1005-1012; DOI: https://doi.org/10.1124/dmd.30.9.1005

  3. Duanmu, Zhengbo

    1. Effects of Dexamethasone on Aryl (SULT1A1)- and Hydroxysteroid (SULT2A1)-Sulfotransferase Gene Expression in Primary Cultured Human Hepatocytes
      Zhengbo Duanmu, Deborah Locke, Jeffrey Smigelski, Wei Wu, Michael S. Dahn, Charles N. Falany, Thomas A. Kocarek and Melissa Runge-Morris
      Drug Metabolism and Disposition September 2002, 30 (9) 997-1004; DOI: https://doi.org/10.1124/dmd.30.9.997

E

  1. Edwards, Geoffrey

    1. Glucuronidation of Dihydroartemisinin in Vivo and by Human Liver Microsomes and Expressed UDP-Glucuronosyltransferases
      Kenneth F. Ilett, Brian T. Ethell, James L. Maggs, Timothy M. E. Davis, Kevin T. Batty, Brian Burchell, Tran Quang Binh, Le Thi Anh Thu, Nguyen Canh Hung, Munir Pirmohamed, B. Kevin Park and Geoffrey Edwards
      Drug Metabolism and Disposition September 2002, 30 (9) 1005-1012; DOI: https://doi.org/10.1124/dmd.30.9.1005

  2. El-Sankary, Wafaa

    1. Glucocorticoid-Mediated Induction of CYP3A4 is Decreased by Disruption of a Protein: DNA Interaction Distinct from the Pregnane X Receptor Response Element
      Wafaa El-Sankary, Vincent Bombail, G. Gordon Gibson and Nick Plant
      Drug Metabolism and Disposition September 2002, 30 (9) 1029-1034; DOI: https://doi.org/10.1124/dmd.30.9.1029

  3. Ethell, Brian T.

    1. Glucuronidation of Dihydroartemisinin in Vivo and by Human Liver Microsomes and Expressed UDP-Glucuronosyltransferases
      Kenneth F. Ilett, Brian T. Ethell, James L. Maggs, Timothy M. E. Davis, Kevin T. Batty, Brian Burchell, Tran Quang Binh, Le Thi Anh Thu, Nguyen Canh Hung, Munir Pirmohamed, B. Kevin Park and Geoffrey Edwards
      Drug Metabolism and Disposition September 2002, 30 (9) 1005-1012; DOI: https://doi.org/10.1124/dmd.30.9.1005

F

  1. Falany, Charles N.

    1. Effects of Dexamethasone on Aryl (SULT1A1)- and Hydroxysteroid (SULT2A1)-Sulfotransferase Gene Expression in Primary Cultured Human Hepatocytes
      Zhengbo Duanmu, Deborah Locke, Jeffrey Smigelski, Wei Wu, Michael S. Dahn, Charles N. Falany, Thomas A. Kocarek and Melissa Runge-Morris
      Drug Metabolism and Disposition September 2002, 30 (9) 997-1004; DOI: https://doi.org/10.1124/dmd.30.9.997

  2. Findlay, John W. A.

    1. Disposition of a Specific Cyclooxygenase-2 Inhibitor, Valdecoxib, in Human
      Josh J. Yuan, Dai-chang Yang, Ji Y. Zhang, Roy Bible, Aziz Karim and John W. A. Findlay
      Drug Metabolism and Disposition September 2002, 30 (9) 1013-1021; DOI: https://doi.org/10.1124/dmd.30.9.1013

  3. Funae, Yoshihiko

    1. Catalytic Specificity of CYP2D Isoforms in Rat and Human
      Toyoko Hiroi, Toshio Chow, Susumu Imaoka and Yoshihiko Funae
      Drug Metabolism and Disposition September 2002, 30 (9) 970-976; DOI: https://doi.org/10.1124/dmd.30.9.970

G

  1. Ghosheh, Omar

    1. N-Glucuronidation of Nicotine and Cotinine in Human: Formation of Cotinine Glucuronide in Liver Microsomes and Lack of Catalysis by 10 Examined UDP-Glucuronosyltransferases
      Omar Ghosheh and Edward M. Hawes
      Drug Metabolism and Disposition September 2002, 30 (9) 991-996; DOI: https://doi.org/10.1124/dmd.30.9.991

  2. Gibson, G. Gordon

    1. Glucocorticoid-Mediated Induction of CYP3A4 is Decreased by Disruption of a Protein: DNA Interaction Distinct from the Pregnane X Receptor Response Element
      Wafaa El-Sankary, Vincent Bombail, G. Gordon Gibson and Nick Plant
      Drug Metabolism and Disposition September 2002, 30 (9) 1029-1034; DOI: https://doi.org/10.1124/dmd.30.9.1029

  3. Gillespie, Jennifer S.

    1. The Interactions of a Selective Protein Kinase C Beta Inhibitor with the Human Cytochromes P450
      Barbara J. Ring, Jennifer S. Gillespie, Shelly N. Binkley, Kristina M. Campanale and Steven A. Wrighton
      Drug Metabolism and Disposition September 2002, 30 (9) 957-961; DOI: https://doi.org/10.1124/dmd.30.9.957

H

  1. Halpert, James R.

    1. Differential Oxidation of Mifepristone by Cytochromes P450 3A4 and 3A5: Selective Inactivation of P450 3A4
      Kishore K. Khan, You Qun He, Maria Almira Correia and James R. Halpert
      Drug Metabolism and Disposition September 2002, 30 (9) 985-990; DOI: https://doi.org/10.1124/dmd.30.9.985

  2. Hawes, Edward M.

    1. N-Glucuronidation of Nicotine and Cotinine in Human: Formation of Cotinine Glucuronide in Liver Microsomes and Lack of Catalysis by 10 Examined UDP-Glucuronosyltransferases
      Omar Ghosheh and Edward M. Hawes
      Drug Metabolism and Disposition September 2002, 30 (9) 991-996; DOI: https://doi.org/10.1124/dmd.30.9.991

  3. He, You Qun

    1. Differential Oxidation of Mifepristone by Cytochromes P450 3A4 and 3A5: Selective Inactivation of P450 3A4
      Kishore K. Khan, You Qun He, Maria Almira Correia and James R. Halpert
      Drug Metabolism and Disposition September 2002, 30 (9) 985-990; DOI: https://doi.org/10.1124/dmd.30.9.985

  4. Hiroi, Toyoko

    1. Catalytic Specificity of CYP2D Isoforms in Rat and Human
      Toyoko Hiroi, Toshio Chow, Susumu Imaoka and Yoshihiko Funae
      Drug Metabolism and Disposition September 2002, 30 (9) 970-976; DOI: https://doi.org/10.1124/dmd.30.9.970

  5. Hu, Yiding

    1. Metabolism of the Endocrine Disruptor Pesticide-Methoxychlor by Human P450s: Pathways Involving a Novel Catechol Metabolite
      Yiding Hu and David Kupfer
      Drug Metabolism and Disposition September 2002, 30 (9) 1035-1042; DOI: https://doi.org/10.1124/dmd.30.9.1035

  6. Hung, Nguyen Canh

    1. Glucuronidation of Dihydroartemisinin in Vivo and by Human Liver Microsomes and Expressed UDP-Glucuronosyltransferases
      Kenneth F. Ilett, Brian T. Ethell, James L. Maggs, Timothy M. E. Davis, Kevin T. Batty, Brian Burchell, Tran Quang Binh, Le Thi Anh Thu, Nguyen Canh Hung, Munir Pirmohamed, B. Kevin Park and Geoffrey Edwards
      Drug Metabolism and Disposition September 2002, 30 (9) 1005-1012; DOI: https://doi.org/10.1124/dmd.30.9.1005

I

  1. Ilett, Kenneth F.

    1. Glucuronidation of Dihydroartemisinin in Vivo and by Human Liver Microsomes and Expressed UDP-Glucuronosyltransferases
      Kenneth F. Ilett, Brian T. Ethell, James L. Maggs, Timothy M. E. Davis, Kevin T. Batty, Brian Burchell, Tran Quang Binh, Le Thi Anh Thu, Nguyen Canh Hung, Munir Pirmohamed, B. Kevin Park and Geoffrey Edwards
      Drug Metabolism and Disposition September 2002, 30 (9) 1005-1012; DOI: https://doi.org/10.1124/dmd.30.9.1005

  2. Imaoka, Susumu

    1. Catalytic Specificity of CYP2D Isoforms in Rat and Human
      Toyoko Hiroi, Toshio Chow, Susumu Imaoka and Yoshihiko Funae
      Drug Metabolism and Disposition September 2002, 30 (9) 970-976; DOI: https://doi.org/10.1124/dmd.30.9.970

K

  1. Kalsotra, Auinash

    1. Sexual Dimorphism and Tissue Specificity in the Expression of CYP4F Forms in Sprague Dawley Rats
      Auinash Kalsotra, Sayeepriyadarshini Anakk, Christopher L. Boehme and Henry W. Strobel
      Drug Metabolism and Disposition September 2002, 30 (9) 1022-1028; DOI: https://doi.org/10.1124/dmd.30.9.1022

  2. Karim, Aziz

    1. Disposition of a Specific Cyclooxygenase-2 Inhibitor, Valdecoxib, in Human
      Josh J. Yuan, Dai-chang Yang, Ji Y. Zhang, Roy Bible, Aziz Karim and John W. A. Findlay
      Drug Metabolism and Disposition September 2002, 30 (9) 1013-1021; DOI: https://doi.org/10.1124/dmd.30.9.1013

  3. Khan, Kishore K.

    1. Differential Oxidation of Mifepristone by Cytochromes P450 3A4 and 3A5: Selective Inactivation of P450 3A4
      Kishore K. Khan, You Qun He, Maria Almira Correia and James R. Halpert
      Drug Metabolism and Disposition September 2002, 30 (9) 985-990; DOI: https://doi.org/10.1124/dmd.30.9.985

  4. Kocarek, Thomas A.

    1. Effects of Dexamethasone on Aryl (SULT1A1)- and Hydroxysteroid (SULT2A1)-Sulfotransferase Gene Expression in Primary Cultured Human Hepatocytes
      Zhengbo Duanmu, Deborah Locke, Jeffrey Smigelski, Wei Wu, Michael S. Dahn, Charles N. Falany, Thomas A. Kocarek and Melissa Runge-Morris
      Drug Metabolism and Disposition September 2002, 30 (9) 997-1004; DOI: https://doi.org/10.1124/dmd.30.9.997

  5. Kostrubsky, Vsevolod E.

    1. Effects of Bergamottin on Human and Monkey Drug-Metabolizing Enzymes in Primary Cultured Hepatocytes
      Yuan Hua Wen, Jasminder Sahi, Ellen Urda, Shaila Kulkarni, Kelly Rose, Xianxian Zheng, Jacqueline F. Sinclair, Hongbo Cai, Stephen C. Strom and Vsevolod E. Kostrubsky
      Drug Metabolism and Disposition September 2002, 30 (9) 977-984; DOI: https://doi.org/10.1124/dmd.30.9.977

  6. Kulkarni, Shaila

    1. Effects of Bergamottin on Human and Monkey Drug-Metabolizing Enzymes in Primary Cultured Hepatocytes
      Yuan Hua Wen, Jasminder Sahi, Ellen Urda, Shaila Kulkarni, Kelly Rose, Xianxian Zheng, Jacqueline F. Sinclair, Hongbo Cai, Stephen C. Strom and Vsevolod E. Kostrubsky
      Drug Metabolism and Disposition September 2002, 30 (9) 977-984; DOI: https://doi.org/10.1124/dmd.30.9.977

  7. Kupfer, David

    1. Metabolism of the Endocrine Disruptor Pesticide-Methoxychlor by Human P450s: Pathways Involving a Novel Catechol Metabolite
      Yiding Hu and David Kupfer
      Drug Metabolism and Disposition September 2002, 30 (9) 1035-1042; DOI: https://doi.org/10.1124/dmd.30.9.1035

L

  1. Locke, Deborah

    1. Effects of Dexamethasone on Aryl (SULT1A1)- and Hydroxysteroid (SULT2A1)-Sulfotransferase Gene Expression in Primary Cultured Human Hepatocytes
      Zhengbo Duanmu, Deborah Locke, Jeffrey Smigelski, Wei Wu, Michael S. Dahn, Charles N. Falany, Thomas A. Kocarek and Melissa Runge-Morris
      Drug Metabolism and Disposition September 2002, 30 (9) 997-1004; DOI: https://doi.org/10.1124/dmd.30.9.997

M

  1. Madison, Vincent

    1. Insights from a Three-Dimensional Model into Ligand Binding to Constitutive Active Receptor
      Li Xiao, Xiaoming Cui, Vincent Madison, Ronald E. White and K.-C. Cheng
      Drug Metabolism and Disposition September 2002, 30 (9) 951-956; DOI: https://doi.org/10.1124/dmd.30.9.951

  2. Maggs, James L.

    1. Glucuronidation of Dihydroartemisinin in Vivo and by Human Liver Microsomes and Expressed UDP-Glucuronosyltransferases
      Kenneth F. Ilett, Brian T. Ethell, James L. Maggs, Timothy M. E. Davis, Kevin T. Batty, Brian Burchell, Tran Quang Binh, Le Thi Anh Thu, Nguyen Canh Hung, Munir Pirmohamed, B. Kevin Park and Geoffrey Edwards
      Drug Metabolism and Disposition September 2002, 30 (9) 1005-1012; DOI: https://doi.org/10.1124/dmd.30.9.1005

  3. Meier, Peter J.

    1. Mechanisms of Impaired Biliary Excretion of Acetaminophen Glucuronide after Acute Phenobarbital Treatment or Phenobarbital Pretreatment
      Hao Xiong, Hiroshi Suzuki, Yuichi Sugiyama, Peter J. Meier, Gary M. Pollack and Kim L. R. Brouwer
      Drug Metabolism and Disposition September 2002, 30 (9) 962-969; DOI: https://doi.org/10.1124/dmd.30.9.962

P

  1. Park, B. Kevin

    1. Glucuronidation of Dihydroartemisinin in Vivo and by Human Liver Microsomes and Expressed UDP-Glucuronosyltransferases
      Kenneth F. Ilett, Brian T. Ethell, James L. Maggs, Timothy M. E. Davis, Kevin T. Batty, Brian Burchell, Tran Quang Binh, Le Thi Anh Thu, Nguyen Canh Hung, Munir Pirmohamed, B. Kevin Park and Geoffrey Edwards
      Drug Metabolism and Disposition September 2002, 30 (9) 1005-1012; DOI: https://doi.org/10.1124/dmd.30.9.1005

  2. Pirmohamed, Munir

    1. Glucuronidation of Dihydroartemisinin in Vivo and by Human Liver Microsomes and Expressed UDP-Glucuronosyltransferases
      Kenneth F. Ilett, Brian T. Ethell, James L. Maggs, Timothy M. E. Davis, Kevin T. Batty, Brian Burchell, Tran Quang Binh, Le Thi Anh Thu, Nguyen Canh Hung, Munir Pirmohamed, B. Kevin Park and Geoffrey Edwards
      Drug Metabolism and Disposition September 2002, 30 (9) 1005-1012; DOI: https://doi.org/10.1124/dmd.30.9.1005

  3. Plant, Nick

    1. Glucocorticoid-Mediated Induction of CYP3A4 is Decreased by Disruption of a Protein: DNA Interaction Distinct from the Pregnane X Receptor Response Element
      Wafaa El-Sankary, Vincent Bombail, G. Gordon Gibson and Nick Plant
      Drug Metabolism and Disposition September 2002, 30 (9) 1029-1034; DOI: https://doi.org/10.1124/dmd.30.9.1029

  4. Pollack, Gary M.

    1. Mechanisms of Impaired Biliary Excretion of Acetaminophen Glucuronide after Acute Phenobarbital Treatment or Phenobarbital Pretreatment
      Hao Xiong, Hiroshi Suzuki, Yuichi Sugiyama, Peter J. Meier, Gary M. Pollack and Kim L. R. Brouwer
      Drug Metabolism and Disposition September 2002, 30 (9) 962-969; DOI: https://doi.org/10.1124/dmd.30.9.962

R

  1. Ring, Barbara J.

    1. The Interactions of a Selective Protein Kinase C Beta Inhibitor with the Human Cytochromes P450
      Barbara J. Ring, Jennifer S. Gillespie, Shelly N. Binkley, Kristina M. Campanale and Steven A. Wrighton
      Drug Metabolism and Disposition September 2002, 30 (9) 957-961; DOI: https://doi.org/10.1124/dmd.30.9.957

  2. Rose, Kelly

    1. Effects of Bergamottin on Human and Monkey Drug-Metabolizing Enzymes in Primary Cultured Hepatocytes
      Yuan Hua Wen, Jasminder Sahi, Ellen Urda, Shaila Kulkarni, Kelly Rose, Xianxian Zheng, Jacqueline F. Sinclair, Hongbo Cai, Stephen C. Strom and Vsevolod E. Kostrubsky
      Drug Metabolism and Disposition September 2002, 30 (9) 977-984; DOI: https://doi.org/10.1124/dmd.30.9.977

  3. Runge-Morris, Melissa

    1. Effects of Dexamethasone on Aryl (SULT1A1)- and Hydroxysteroid (SULT2A1)-Sulfotransferase Gene Expression in Primary Cultured Human Hepatocytes
      Zhengbo Duanmu, Deborah Locke, Jeffrey Smigelski, Wei Wu, Michael S. Dahn, Charles N. Falany, Thomas A. Kocarek and Melissa Runge-Morris
      Drug Metabolism and Disposition September 2002, 30 (9) 997-1004; DOI: https://doi.org/10.1124/dmd.30.9.997

S

  1. Sahi, Jasminder

    1. Effects of Bergamottin on Human and Monkey Drug-Metabolizing Enzymes in Primary Cultured Hepatocytes
      Yuan Hua Wen, Jasminder Sahi, Ellen Urda, Shaila Kulkarni, Kelly Rose, Xianxian Zheng, Jacqueline F. Sinclair, Hongbo Cai, Stephen C. Strom and Vsevolod E. Kostrubsky
      Drug Metabolism and Disposition September 2002, 30 (9) 977-984; DOI: https://doi.org/10.1124/dmd.30.9.977

  2. Sinclair, Jacqueline F.

    1. Effects of Bergamottin on Human and Monkey Drug-Metabolizing Enzymes in Primary Cultured Hepatocytes
      Yuan Hua Wen, Jasminder Sahi, Ellen Urda, Shaila Kulkarni, Kelly Rose, Xianxian Zheng, Jacqueline F. Sinclair, Hongbo Cai, Stephen C. Strom and Vsevolod E. Kostrubsky
      Drug Metabolism and Disposition September 2002, 30 (9) 977-984; DOI: https://doi.org/10.1124/dmd.30.9.977

  3. Smigelski, Jeffrey

    1. Effects of Dexamethasone on Aryl (SULT1A1)- and Hydroxysteroid (SULT2A1)-Sulfotransferase Gene Expression in Primary Cultured Human Hepatocytes
      Zhengbo Duanmu, Deborah Locke, Jeffrey Smigelski, Wei Wu, Michael S. Dahn, Charles N. Falany, Thomas A. Kocarek and Melissa Runge-Morris
      Drug Metabolism and Disposition September 2002, 30 (9) 997-1004; DOI: https://doi.org/10.1124/dmd.30.9.997

  4. Strobel, Henry W.

    1. Sexual Dimorphism and Tissue Specificity in the Expression of CYP4F Forms in Sprague Dawley Rats
      Auinash Kalsotra, Sayeepriyadarshini Anakk, Christopher L. Boehme and Henry W. Strobel
      Drug Metabolism and Disposition September 2002, 30 (9) 1022-1028; DOI: https://doi.org/10.1124/dmd.30.9.1022

  5. Strom, Stephen C.

    1. Effects of Bergamottin on Human and Monkey Drug-Metabolizing Enzymes in Primary Cultured Hepatocytes
      Yuan Hua Wen, Jasminder Sahi, Ellen Urda, Shaila Kulkarni, Kelly Rose, Xianxian Zheng, Jacqueline F. Sinclair, Hongbo Cai, Stephen C. Strom and Vsevolod E. Kostrubsky
      Drug Metabolism and Disposition September 2002, 30 (9) 977-984; DOI: https://doi.org/10.1124/dmd.30.9.977

  6. Sugiyama, Yuichi

    1. Mechanisms of Impaired Biliary Excretion of Acetaminophen Glucuronide after Acute Phenobarbital Treatment or Phenobarbital Pretreatment
      Hao Xiong, Hiroshi Suzuki, Yuichi Sugiyama, Peter J. Meier, Gary M. Pollack and Kim L. R. Brouwer
      Drug Metabolism and Disposition September 2002, 30 (9) 962-969; DOI: https://doi.org/10.1124/dmd.30.9.962

  7. Suzuki, Hiroshi

    1. Mechanisms of Impaired Biliary Excretion of Acetaminophen Glucuronide after Acute Phenobarbital Treatment or Phenobarbital Pretreatment
      Hao Xiong, Hiroshi Suzuki, Yuichi Sugiyama, Peter J. Meier, Gary M. Pollack and Kim L. R. Brouwer
      Drug Metabolism and Disposition September 2002, 30 (9) 962-969; DOI: https://doi.org/10.1124/dmd.30.9.962

T

  1. Thu, Le Thi Anh

    1. Glucuronidation of Dihydroartemisinin in Vivo and by Human Liver Microsomes and Expressed UDP-Glucuronosyltransferases
      Kenneth F. Ilett, Brian T. Ethell, James L. Maggs, Timothy M. E. Davis, Kevin T. Batty, Brian Burchell, Tran Quang Binh, Le Thi Anh Thu, Nguyen Canh Hung, Munir Pirmohamed, B. Kevin Park and Geoffrey Edwards
      Drug Metabolism and Disposition September 2002, 30 (9) 1005-1012; DOI: https://doi.org/10.1124/dmd.30.9.1005

U

  1. Urda, Ellen

    1. Effects of Bergamottin on Human and Monkey Drug-Metabolizing Enzymes in Primary Cultured Hepatocytes
      Yuan Hua Wen, Jasminder Sahi, Ellen Urda, Shaila Kulkarni, Kelly Rose, Xianxian Zheng, Jacqueline F. Sinclair, Hongbo Cai, Stephen C. Strom and Vsevolod E. Kostrubsky
      Drug Metabolism and Disposition September 2002, 30 (9) 977-984; DOI: https://doi.org/10.1124/dmd.30.9.977

W

  1. Wen, Yuan Hua

    1. Effects of Bergamottin on Human and Monkey Drug-Metabolizing Enzymes in Primary Cultured Hepatocytes
      Yuan Hua Wen, Jasminder Sahi, Ellen Urda, Shaila Kulkarni, Kelly Rose, Xianxian Zheng, Jacqueline F. Sinclair, Hongbo Cai, Stephen C. Strom and Vsevolod E. Kostrubsky
      Drug Metabolism and Disposition September 2002, 30 (9) 977-984; DOI: https://doi.org/10.1124/dmd.30.9.977

  2. White, Ronald E.

    1. Insights from a Three-Dimensional Model into Ligand Binding to Constitutive Active Receptor
      Li Xiao, Xiaoming Cui, Vincent Madison, Ronald E. White and K.-C. Cheng
      Drug Metabolism and Disposition September 2002, 30 (9) 951-956; DOI: https://doi.org/10.1124/dmd.30.9.951

  3. Wrighton, Steven A.

    1. The Interactions of a Selective Protein Kinase C Beta Inhibitor with the Human Cytochromes P450
      Barbara J. Ring, Jennifer S. Gillespie, Shelly N. Binkley, Kristina M. Campanale and Steven A. Wrighton
      Drug Metabolism and Disposition September 2002, 30 (9) 957-961; DOI: https://doi.org/10.1124/dmd.30.9.957

  4. Wu, Wei

    1. Effects of Dexamethasone on Aryl (SULT1A1)- and Hydroxysteroid (SULT2A1)-Sulfotransferase Gene Expression in Primary Cultured Human Hepatocytes
      Zhengbo Duanmu, Deborah Locke, Jeffrey Smigelski, Wei Wu, Michael S. Dahn, Charles N. Falany, Thomas A. Kocarek and Melissa Runge-Morris
      Drug Metabolism and Disposition September 2002, 30 (9) 997-1004; DOI: https://doi.org/10.1124/dmd.30.9.997

X

  1. Xiao, Li

    1. Insights from a Three-Dimensional Model into Ligand Binding to Constitutive Active Receptor
      Li Xiao, Xiaoming Cui, Vincent Madison, Ronald E. White and K.-C. Cheng
      Drug Metabolism and Disposition September 2002, 30 (9) 951-956; DOI: https://doi.org/10.1124/dmd.30.9.951

  2. Xiong, Hao

    1. Mechanisms of Impaired Biliary Excretion of Acetaminophen Glucuronide after Acute Phenobarbital Treatment or Phenobarbital Pretreatment
      Hao Xiong, Hiroshi Suzuki, Yuichi Sugiyama, Peter J. Meier, Gary M. Pollack and Kim L. R. Brouwer
      Drug Metabolism and Disposition September 2002, 30 (9) 962-969; DOI: https://doi.org/10.1124/dmd.30.9.962

Y

  1. Yang, Dai-chang

    1. Disposition of a Specific Cyclooxygenase-2 Inhibitor, Valdecoxib, in Human
      Josh J. Yuan, Dai-chang Yang, Ji Y. Zhang, Roy Bible, Aziz Karim and John W. A. Findlay
      Drug Metabolism and Disposition September 2002, 30 (9) 1013-1021; DOI: https://doi.org/10.1124/dmd.30.9.1013

  2. Yuan, Josh J.

    1. Disposition of a Specific Cyclooxygenase-2 Inhibitor, Valdecoxib, in Human
      Josh J. Yuan, Dai-chang Yang, Ji Y. Zhang, Roy Bible, Aziz Karim and John W. A. Findlay
      Drug Metabolism and Disposition September 2002, 30 (9) 1013-1021; DOI: https://doi.org/10.1124/dmd.30.9.1013

Z

  1. Zhang, Ji Y.

    1. Disposition of a Specific Cyclooxygenase-2 Inhibitor, Valdecoxib, in Human
      Josh J. Yuan, Dai-chang Yang, Ji Y. Zhang, Roy Bible, Aziz Karim and John W. A. Findlay
      Drug Metabolism and Disposition September 2002, 30 (9) 1013-1021; DOI: https://doi.org/10.1124/dmd.30.9.1013

  2. Zheng, Xianxian

    1. Effects of Bergamottin on Human and Monkey Drug-Metabolizing Enzymes in Primary Cultured Hepatocytes
      Yuan Hua Wen, Jasminder Sahi, Ellen Urda, Shaila Kulkarni, Kelly Rose, Xianxian Zheng, Jacqueline F. Sinclair, Hongbo Cai, Stephen C. Strom and Vsevolod E. Kostrubsky
      Drug Metabolism and Disposition September 2002, 30 (9) 977-984; DOI: https://doi.org/10.1124/dmd.30.9.977
Back to top

In this issue

Advertisement